Filing Details
- Accession Number:
- 0001610717-24-000232
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-07 17:06:34
- Reporting Period:
- 2024-05-06
- Accepted Time:
- 2024-05-07 17:06:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1626971 | Corvus Pharmaceuticals Inc. | CRVS | Pharmaceutical Preparations (2834) | 464670809 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1664506 | Benton William Jones | C/O Corvus Pharmaceuticals, Inc. 863 Mitten Road, Suite 102 Burlingame CA 94010 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-06 | 20,000 | $1.73 | 153,773 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant (Right to Buy) | Acquisiton | 2024-05-06 | 19,357 | $0.00 | 19,357 | $3.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 19,357 | 2024-05-06 | 2025-06-30 | No | 4 | P | Direct |
Footnotes
- Issued at no additional consideration to the Reporting Person in connection with their subscription for shares of the Issuer's Common Stock at a price of $1.7312.
Billionaire Hedge Funds
